Alzheimer's Disease Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with early Alzheimer's disease, meaning they have either mild memory and thinking difficulties linked to Alzheimer's, or mild dementia caused by Alzheimer's.
- People whose memory and thinking test scores fall within a specific range that matches what doctors expect to see in early Alzheimer's disease (confirm with trial site for exact score details).
- People whose blood test results show biological signs of Alzheimer's disease, based on a specific marker called phosphorylated tau-217, as defined by 2024 medical guidelines.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have other brain, mental health, or serious physical health conditions that could also explain their memory or thinking difficulties — for example, significant stroke-related brain changes, alcohol dependence, untreated severe depression, or serious heart, kidney, or liver problems, or who take certain medications that can heavily affect thinking.
- People who have a history of seizures, or who have metal that cannot be removed in or near their head, as these make the brain stimulation treatment used in this trial unsafe for them.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 713-798-5989
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MMSE; Clinical Dementia Rating scale (CDR); Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog); Verbal learning test; Boston Naming Test; Trail making test; Digital Span
Can't join this trial?
Data last synced from ClinicalTrials.gov: 3 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.